• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18637 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     Centre for Clinical Effectiveness (CCE) Tourniquets in phlebotomy
1998     Health Council of the Netherlands Gezondheidsraad (GR) Toward the effective use of benzodiazepines
2015     NIHR Health Services and Delivery Research programme Towards a framework for enhancing procurement and supply chain management practice in the NHS: lessons for managers and clinicians from a synthesis of the theoretical and empirical literature
2013     NIHR Health Services and Delivery Research programme Towards a framework for enhancing the performance of NHS boards: a synthesis of the evidence about board governance, board effectiveness and board development
2015     Belgian Health Care Knowledge Centre (KCE) Towards a guided and phased introduction of high-risk medical devices in Belgium
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamin A
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamin D
2009     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamins and minerals
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an optimal use of folic acid
2004     NIHR Health Technology Assessment programme Towards efficient guidelines: 1. When to develop guidelines- systematic review
2003     NIHR Health Technology Assessment programme Towards efficient guidelines: how to monitor guideline use in primary care
2013     NIHR Health Services and Delivery Research programme Towards equitable commissioning for our multiethnic society: a mixed-methods qualitative investigation of evidence utilisation by strategic commissioners and public health managers
2005     NIHR Health Technology Assessment programme Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2016     NIHR Health Services and Delivery Research programme Towards improved decision support in the assessment and management of pain for people with dementia in hospital: a systematic meta-review and observational study
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards maintaining an optimum iodine intake
2010     NIHR Health Technology Assessment programme Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives
2010     HAYES, Inc. Townes-Brocks Syndrome (TBS)
2011     HAYES, Inc. TP53 (p53) testing for Li-Fraumeni Syndrome (LFS)
2012     HAYES, Inc. TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2011     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for advanced and/or metastatic translocation-related sarcomas - first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for relapsed ovarian cancer
2006     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for second and third-line treatment of soft tissue sarcoma: horizon scanning technology ultra-orphan note
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trabectedin (Yondelis) for second-line recurrent platinum-sensitive ovarian cancer
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trabectedin (Yondelis®) for advanced soft tissue sarcoma
2003     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin for soft tissue sarcoma - horizon scanning review
2010     NIHR Health Technology Assessment programme Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
2010     National Institute for Health and Clinical Excellence (NICE) Trabectedin for the treatment of advanced soft tissue sarcoma
2011     NIHR Health Technology Assessment programme Trabectedin for the treatment of relapsed ovarian cancer
2011     National Institute for Health and Clinical Excellence (NICE) Trabectedin for the treatment of relapsed ovarian cancer
2009     HAYES, Inc. Trabectome (NeoMedix Corp.) for treatment of glaucoma
2021     Center for Evidence-based Practice (CEP) Tracheostomy or endotracheal tubes and subglottic suctioning
2014     HAYES, Inc. Tracleer (Bosentan; Actelion Pharmaceuticals Ltd.) for treatment of digital ulcers in patients with scleroderma
2002     NIHR Health Technology Assessment programme Training for patient and public ('consumer') involvement in health and social care research: a study of training provision and participants' experiences
2018     NIHR Health Technology Assessment programme Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT
2002     Agency for Healthcare Research and Quality (AHRQ) Training of clinicians for public health events relevant to bioterrorism preparedness
2004     Agency for Healthcare Research and Quality (AHRQ) Training of hospital staff to respond to a mass casualty incident
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol compared with opioids for pain: a review of addiction potential
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trametinib in combination with dabrafenib for V600 BRAF positive advanced malignant melanoma – first line
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines
2019     NIHR Health Technology Assessment programme Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT
2002     New Zealand Health Technology Assessment (NZHTA) Trans-gender reassignment surgery
2013     HAYES, Inc. Transabdominal Cervical Cerclage (TAC) for the prevention of miscarriage
2004     Medical Services Advisory Committee (MSAC) Transanal endoscopic microsurgery
2007     HAYES, Inc. Transanal endoscopic microsurgery for rectal carcinoma
2009     HAYES, Inc. Transanal endoscopic microsurgery for rectal carcinoma
2013     HAYES, Inc. Transanal hemorrhoidal dearterialization
2010     HTA Database, Centre for Reviews and Dissemination, University of York Transarterial chemoembolization for palliation of unresectable liver metastases from colorectal cancer (Protocol for a systematic review)
2012     HAYES, Inc. Transarterial chemoembolization plus radiofrequency ablation for liver cancer
2013     HAYES, Inc. Transarterial embolization with embozene microspheres (CeloNova BioSciences Inc.) for treatment of hepatocellular carcinoma and other liver tumors
2012     HAYES, Inc. Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012     New Zealand National Health Committee (NHC) Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2011     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults
2014     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk
2014     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery
2011     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults. This evidence note updates evidence note 33 published in March 2011
2020     Health Technology Wales (HTW) Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2013     Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2012     Medical Advisory Secretariat (MAS) Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2018     European Network for Health Technology Assessment (EUnetHTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2021     Norwegian Institute of Public Health (NIPH) Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment
2011     Belgian Health Care Knowledge Centre (KCE) Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2012     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2013     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2013     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for the treatment of aortic valve stenosis: an evidence update
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2015     Medical Services Advisory Committee (MSAC) Transcatheter aortic valve implantation via transfemoral or transapical delivery
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2006     Haute Autorite de sante (HAS) Transcatheter closure of a patent foramen ovale
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transcatheter closure of atrial septal defects
2013     Medical Services Advisory Committee (MSAC) Transcatheter closure of patent ductus arteriosus
2017     HAYES, Inc. Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2002     HAYES, Inc. Transcatheter closure of septal defects
2008     HAYES, Inc. Transcatheter closure of ventricular septal defects
2010     National Institute for Health and Clinical Excellence (NICE) Transcatheter endovascular closure of perimembranous ventricular septal defect
2016     Agenzia nazionale per i servizi sanitari regionali (Agenas) Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation
2014     Medical Services Advisory Committee (MSAC) Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2015     HAYES, Inc. Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2007     HAYES, Inc. Transconjunctival sutureless vitrectomy using the Millennium TSV25 system (Bausch&Lomb Inc.)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for Alzheimer's disease
2009     NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for major depressive disorder
2017     HAYES, Inc. Transcranial direct current stimulation for depression
2014     HAYES, Inc. Transcranial direct current stimulation for depression
2013     Malaysian Health Technology Assessment (MaHTAS) Transcranial Doppler (TCD) ultrasound and cerebral computed tomography perfusion (CTP) for aneurysmal subarachnoid haemorrhage (SAH)
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Transcranial doppler ultrasonography: main clinical applications
2015     The Regional Health Technology Assessment Centre (HTA-centrum) Transcranial Magnetic Resonance Guided Focused Ultrasound treatment of essential tremor, neuropathic pain and Parkinson's disease
2016     Adelaide Health Technology Assessment (AHTA) Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2010     VA Technology Assessment Program (VATAP) Transcranial magnetic stimulation (TMS) for depression